/ News, Research
New Approach to Treat Patients with Checkpoint Inhibitor-induced Adverse Events (Apostolova Lab)
Immune checkpoint inhibitors (ICI), such as anti-PD-1 and anti-CTLA4 antibodies, enhance anti-cancer immunity and are a potent treatment for several types of cancer. However, overt activation of the immune system can also cause severe…